Grace Therapeutics Q1 2026 Earnings EPS Surprise of 5098 Despite No Revenue as Stock Declines AMGN Q1 2026 Earnings EPS Surpasses Estimates by 614 Stock Edges Higher Kalaris Therapeutics Inc KLRS Q1 2026 Earnings NarrowerthanExpected Loss Highlights Disciplined Spending SNPS Q1 2026 Earnings Earnings Beat Estimates Stock Rises on Strong Performance Versus Systems Inc VS Q4 2025 Earnings Narrowing Loss Amid Flat Revenue Disclosure Curbline Properties Q1 2026 Earnings Miss on EPS Stock Edges Higher